Biomarkers & Combination Therapy May Be the Path Ahead for Immunotherapy

Biomarkers & Combination Therapy May Be the Path Ahead for Immunotherapy

User Photo
AnnualMeeting-SITC2017

3 years
607 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ezra E.W. Cohen, MD of University of California, San Diego explains how biomarkers and combination therapy may be the path ahead for immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Up Next Autoplay
User Photo